Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Abstract Text:

Margaret A Piggott,Clive G Ballard,Elise Rowan,Clive Holmes,Ian G McKeith,Evelyn Jaros,Robert H Perry,Elaine K Perry,Margaret A Piggott,Clive G Ballard,Elise Rowan,Clive Holmes,Ian G McKeith,Evelyn Jaros,Robert H Perry,Elaine K Perry,

Dementia with Lewy bodies (DLB) is a progressive dementia frequently accompanied by psychotic symptoms. Similar symptoms can occur in Alzheimer's disease (AD) to a lesser extent. The use of neuroleptic medication to treat psychosis in both diseases is of modest efficacy and can induce severe adverse reactions in DLB. Dopamine D2 receptors in the cerebral cortex are the putative target for the antipsychotic action of these drugs, but the status of these receptors in DLB is unknown. Autoradiography was used to examine the density D2 receptors in postmortem temporal cortex tissue from prospectively assessed patients with neuropathologically confirmed DLB and AD. D2 receptors were substantially (over 40%) and significantly (P < 0.001) reduced in temporal cortex in DLB, and in DLB with concomitant Alzheimer pathology, but was not significantly changed in AD. This reduction correlated with greater cognitive decline (P < 0.01), but was not significantly related to visual or auditory hallucinations or delusions. D2 receptor density was inversely correlated with cortical Lewy body pathology in the neocortex (P < 0.001). The specific loss of D2 receptors associated with Lewy body pathology, in conjunction with our previous finding of low D2 receptors in striatum in DLB, provides a possible explanation for neuroleptic intolerance. That the reduction of D2 receptors correlated with cognitive decline suggests that neuroleptics, as dopamine D2 receptor antagonists, may have a deleterious effect on cognition in DLB.

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Publishing Authors By Initials

MA Piggott,CG Ballard,E Rowan,C Holmes,IG McKeith,E Jaros,RH Perry,EK Perry,MA Piggott,CG Ballard,E Rowan,C Holmes,IG McKeith,E Jaros,RH Perry,EK Perry,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Synapse (New York, N.Y.)

VOLUME: 61

Page Numbers: 903-11

Journal Abbreviation: Synapse

ISSN: 0887-4476

DAY: 10

MONTH: Nov

YEAR: 2007

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8806914

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.

AFFILIATION: Institute for Ageing and Health, Wolfson Research Centre, Newcastle General Hospital, Newcastle-upon-Tyne NE4 6BE, United Kingdom. m.a.piggott@ncl.ac.uk

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Synapse

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline Related Publications

• "Stay away from them until you're old enough to make a decision": tobacco company testimony about youth smoking initiation.
• 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases.
• A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor.
• Adults with autism show increased sensitivity to outcomes at low error rates during decision-making.
• Balanced production of ribosomal proteins.
• Bias, benefit, or both: evaluating new glioma therapies.
• Comparison of two methods for measuring tongue pressure during swallowing in people with head and neck cancer.
• Congenital glioblastoma: a clinicopathologic and genetic analysis.
• Constraints on practice.
• Gender identity and adjustment in black, Hispanic, and white preadolescents.
• Glioblastoma.
• Hierarchy of iron uptake systems: Yfu and Yiu are functional in Yersinia pestis.
• Identification of critical amino acid residues in the plague biofilm Hms proteins.
• Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts.
• On-board Imaging - the Ipswich Experience.
• Oxidative damage to RNA in neurodegenerative diseases.
• Power in Numbers: Using EPINet Data to Promote Protective Policies for Healthcare Workers.
• Rasagiline: a review of its use in the management of Parkinson's disease.
• Rectus sheath hematoma: a series of unfortunate events.
• Road effects on abundance and fitness of Galápagos lava lizards (Microlophus albemarlensis).
• Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
• Selective reporting of pharmaceutical data leads major medical journals to change editorial policy.
• Small cell lung cancer: have we made any progress over the last 25 years?
• Spotlight on ramipril in the prevention of cardiovascular outcomes.
• Tacrolimus once-daily formulation : in the prophylaxis of transplant rejection in renal or liver allograft recipients.
• The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients.
• Vascular oxidative stress in Alzheimer disease.
• Walking in a city neighbourhood, paving the way.
• Work-related ladder fall fractures: identification and diagnosis validation using narrative text.
• You can make a difference.